Minoxidil

Minoxidil, the active ingredient in Minoxidil, is a vasodilator presented as an unknown/unknown for cutaneous use. It treats androgenetic alopecia and other hair loss conditions in adults. GNH USA supplies Minoxidil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Minoxidil is used to address hair loss disorders by influencing the hair growth cycle. - Androgenetic alopecia: promotes regrowth of scalp hair in male and female pattern baldness. - Female pattern hair loss: helps increase hair density and thickness on the crown. - Telogen effluvium: may accelerate the return of normal hair growth after shedding episodes.

Adverse reactions may occur with topical minoxidil use.

Common Side Effects: - Scalp irritation: redness, itching, or burning sensation at the application site. - Dryness or flaking of the scalp. - Unwanted facial or body hair (hypertrichosis). - Contact dermatitis: rash or eczema where applied. - Temporary shedding of existing hair during initial weeks.

Serious or Rare Side Effects: - Severe allergic reaction: angioedema, swelling of face or lips. - Chest pain or palpitations indicating systemic vasodilatory effect. - Rapid heart rate (tachycardia). - Dizziness or light‑headedness. - Unexplained weight gain or peripheral edema. - Sudden onset of severe scalp inflammation.

Before using minoxidil, consider the following safety measures. - Pregnancy: safety not established; consult a healthcare professional before use. - Breastfeeding: unknown safety profile; avoid unless advised by a physician. - Cardiovascular disease: caution in patients with hypertension or heart conditions due to vasodilatory action. - Damaged skin: do not apply to irritated, inflamed, or broken skin. - Concomitant topical agents: monitor for increased irritation when used with other hair‑care products. - Store at ambient temperature: keep in the original container, protect from moisture and direct light.

Minoxidil may interact with other medicines; review the following categories.

Major Interactions (Avoid): - Oral antihypertensives: additive blood‑pressure lowering effect. - Other vasodilators (e.g., nitroglycerin): risk of excessive hypotension. - Topical irritants such as retinoids: heightened skin irritation.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): possible fluid retention. - Diuretics: may amplify blood‑pressure changes. - Beta‑blockers: monitor cardiovascular response.